Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR - ICR / Cancer Research Society Partnership - Research Grants

University of Alberta

$60,000.00

Transcriptional requirements for pro-cachectic gMDSC amplification

FY 2019-20

Summary
Cachexia or wasting consists of the progressive loss of fat, but most remarkably muscular mass, resulting in a loss of muscle and cardiorespiratory fitness. Several clinical studies suggest that the development of cachexia is associated with a very poor cancer outcome, leading to the idea that cachexia is the main reason for death in many types of cancer. Unfortunately, there are currently no treatments against muscle wasting. We have discovered that some cells of the immune system release signals that cause the muscles to shrink. In this study, we are investigating the development of these cancer-specific immune cells in order to try to harness this knowledge to treat muscle wasting and improve the survival and the quality of life of cancer patients.
Program
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
421955
Name
Clemente Casares Javier
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Special Cases
Projecttitle
Transcriptional requirements for pro-cachectic gMDSC amplification
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$60,000
Cihrequipment2
$0
Programname2
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Keyworddelim
Cancer Cachexia; Gmdscs; Transcription Factors
Abstract
Cachexia or wasting consists of the progressive loss of fat, but most remarkably muscular mass, resulting in a loss of muscle and cardiorespiratory fitness. Several clinical studies suggest that the development of cachexia is associated with a very poor cancer outcome, leading to the idea that cachexia is the main reason for death in many types of cancer. Unfortunately, there are currently no treatments against muscle wasting. We have discovered that some cells of the immune system release signals that cause the muscles to shrink. In this study, we are investigating the development of these cancer-specific immune cells in order to try to harness this knowledge to treat muscle wasting and improve the survival and the quality of life of cancer patients.
Competitiondate
202002
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Clemente Casares, Javier
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Cancer Research~ $60,000~ $0~
University of Alberta - $60,000 Grant (2019-20) | Canada Spends